sglt2 inhibitors vs glp-1 agonists View of Diabetes medications with cardiovascular protection after HARMONY Outcomes and DECLARE-TIMI 58: could metformin, pioglitazone, and long-acting receptor complement each other to save lives by different mechanisms? Cardiorenal Protection: Potential of SGLT2
Description
Inflammation, mitochondrial impairment, oxidative stress, and insulin resistance may all contribute to disease progression
doi: 10.1016/j.molmet.2022.101550 51 RazzakiTSWeinerAShuklaAP
MeAgain is a technology platform and does not provide medical advice, diagnosis, or treatment
Orders outside of the contiguous US, including Alaska & Hawaii will be charged $8 for shipping
The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases
Genetics and other individual factors are likely involved
